Preserved SARS-CoV-2 neutralizing IgG activity of in-house manufactured COVID-19 convalescent plasma

In the current study, we aimed to evaluate the neutralizing IgG activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as well as the coagulation factors of convalescent plasmas which we manufactured in-house without a fast-freezing technique.

Source: Transfusion and Apheresis Science - December 28, 2022 Category: Hematology Authors: Makoto Inada, Tomiteru Togano, Mari Terada, Katsuyuki Shiratori, Shinya Tsuzuki, Yuki Takamatsu, Sho Saito, Akira Hangaishi, Shinichiro Morioka, Satoshi Kutsuna, Kenji Maeda, Hiroaki Mitsuya, Norio Ohmagari Source Type: research